The Mpox Outbreak Shows We’ve Learned Nothing From COVID

Vaccines have started to trickle into the Democratic Republic of Congo after a lethal mpox outbreak, but it’s nowhere near enough. The latest health crisis demonstrates once again the perils of relying on Big Pharma to produce vaccines.

Houston Chronicle

Smallpox and Monkeypox vaccines at a Galveston County Health District mobile clinic, Saturday, Sept. 3, 2022, in Galveston. (Marie D. De Jesus / Houston Chronicle via Getty Images)


At the end of last week and after several delays, a first shipment of monkeypox, or mpox, vaccine donations finally arrived in the Democratic Republic of Congo (DRC). While the Big Pharma corporations and the Western governments who’ve been sitting on stockpiles of these vaccines for two years might try to claim a PR success, the truth is that the whole crisis exposes the deeply neocolonial nature of the global health system.

Despite the lessons that we should have learned from the COVID-19 pandemic about the lethal inequities that shape the production and supply of medical treatments, those who benefit from the status quo are still resisting the necessary transformation. As long as the current system remains in place, it will pose a serious danger to public health throughout the world.

Myths of Solidarity

Paul Chaplin is the CEO of Bavarian Nordic, the company that owns the Jynneos vaccine shown to be most effective against mpox. He declared that he was proud to meet urgent health needs in the DRC. Stella Kyriakides, the European commissioner for health and food safety, stated that the EU was pleased to be acting “in partnership and global solidarity” with Africa.

Sorry, but this article is available to active subscribers only. Please log in or become a subscriber.